Lepzacitinib structure
|
Common Name | Lepzacitinib | ||
|---|---|---|---|---|
| CAS Number | 2321488-47-3 | Molecular Weight | 355.39 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H21N5O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LepzacitinibLepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1]. |
| Name | Lepzacitinib |
|---|
| Description | Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
JAK 1/3[1] |
| References |
| Molecular Formula | C18H21N5O3 |
|---|---|
| Molecular Weight | 355.39 |